لینک کالا در سایت سیگما ( کلیک کنید )
لینک کالا در سایت USP ( کلیک کنید )
برگه انالیز کالا ( کلیک کنید )
United States Pharmacopeia (USP) Reference Standard
Empirical Formula (Hill Notation):
C256H381N65O79S6
CAS Number:
Molecular Weight:
5825.54
UNSPSC Code:
41116107
NACRES:
NA.24
insulin
solid
USP
USP Biologics
pharmaceutical (small molecule)
pharmaceutical
Insulin Aspart is a rapid-acting insulin analog produced by recombinant DNA technology. It differs from human insulin by a single amino acid substitution, enhancing its absorption rate. This modification allows for improved postprandial glucose control in diabetic patients.
The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
Insulin aspart USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
Insulin Aspart Injection
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Technical Article available
Sales restrictions may apply.
This product is part of the USP Biologics program.